Causes of Refractory Reflux Symptoms in Patients Receiving Proton Pump Inhibitor Therapy Incorrect initial diagnosis Nonreflux esophagitispill injury, skin diseases, eosinophilic esophagitis, infection Heart disease Chest wall pain Gastric pain Additional diagnoses Dyspepsia Delayed gastric emptying Gastritis Peptic ulcer disease Nonulcer dyspepsia Inadequate acid suppression Noncompliance Rapid metabolizers of proton pump inhibitors Dose timing Insufficient dose Zollinger-Ellison syndrome Nonacid reflux Adenocarcinoma in Barrett esophagus Postoperative reflux Partial gastrectomy Vertical-banded gastroplasty Esophageal dysmotility Spasm Achalasia Nutcracker esophagus Functional chest pain Hypersensitive esophagus Somatic features of depression Functional heartburn Free regurgitation Absence of lower esophageal sphincter tone Large hiatal hernia Achalasia Rumination rumination or gastroparesis) or functional conditions (eg, functional heartburn)
ICD-10-CM lists them as Excludes1 notation, so they represent mutually exclusive clinical scenarios
Megaloblastic anemia has been reported to be related to thyroid diseases, but this relationship is still controversial [27, 28]
In the present study, we further demonstrate that BPC 157 can promote the phosphorylation of Src and Cav-1, providing a strong explanation for the activation and endocytosis of VEGFR2 by BPC 157 as reported in our previous study
We will continue to evaluate new, compliant therapies as they emerge, ensuring that our patients always have access to the safest and most effective treatments available
Many people report feeling more motivated to move and exercise once they begin taking Phentermine
